No. of Pages: 120 | Report Code: TIPRE00014170 | Category: Life Sciences
La thérapie antivirale est l\'une des branches les plus intéressantes de la virologie. Ces thérapies reposent sur plusieurs stratégies : les antiviraux à action directe ciblent les protéines, les enzymes ou les acides nucléiques viraux ; les anticorps passifs neutralisent les virus en circulation ; et plusieurs autres antiviraux ciblent des protéines cellulaires ou des processus essentiels à la réplication virale.
L\'anti- Le marché des thérapies virales devrait atteindre 21 122,66 millions de dollars US d’ici 2027, contre 11 401,67 millions de dollars US en 2019. Le marché devrait croître à un TCAC de 8,1 % entre 2020 et 2027. La croissance du marché est attribuée à la prévalence croissante des maladies virales et à l’épidémie de pandémie de COVID-19, à l’augmentation des dépenses de R&D des sociétés pharmaceutiques et au soutien croissant du gouvernement aux activités de recherche et aux essais cliniques. Cependant, le coût élevé du développement de médicaments entrave dans une certaine mesure la croissance du marché.
Dans En termes de type, le segment des médicaments de marque représentait une part plus importante du marché européen des thérapies antivirales en 2019. En termes de mécanisme d\'action, le segment des inhibiteurs de la nucléotide polymérase représentait la plus grande part du marché. marché en 2019. En termes d\'application, le segment VIH représentait la plus grande part du marché européen des thérapies antivirales en 2019.
Plusieurs sources primaires et secondaires majeures associées au rapport sur le marché européen des thérapies antivirales sont l\'Organisation mondiale de la santé (OMS), l\'Administration du commerce international (ITA), la Fédération européenne des produits pharmaceutiques. Industries et associations (EFPIA), Réglementation sanitaire internationale (IHR), Association de l\'industrie pharmaceutique britannique, National AIDS Trusts (NAT) et autres.
Strategic insights for Europe Anti-Viral Therapies involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 11,401.67 Million |
| Market Size by 2027 | US$ 21,122.66 Million |
| Global CAGR (2020 - 2027) | 8.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
The regional scope of Europe Anti-Viral Therapies refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Europe Anti-Viral Therapies Market
The Europe Anti-Viral Therapies Market is valued at US$ 11,401.67 Million in 2019, it is projected to reach US$ 21,122.66 Million by 2027.
As per our report Europe Anti-Viral Therapies Market, the market size is valued at US$ 11,401.67 Million in 2019, projecting it to reach US$ 21,122.66 Million by 2027. This translates to a CAGR of approximately 8.1% during the forecast period.
The Europe Anti-Viral Therapies Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Anti-Viral Therapies Market report:
The Europe Anti-Viral Therapies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Anti-Viral Therapies Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Anti-Viral Therapies Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Anti-Viral Therapies Market
